======= PDAP1 ======= == Gene Information == * **Official Symbol**: PDAP1 * **Official Name**: PDGFA associated protein 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=11333|11333]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q13442|Q13442]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PDAP1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PDAP1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/607075|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene is a phosphoprotein that may upregulate the PDGFA-stimulated growth of fibroblasts and also downregulate the mitogenicity of PDGFB. The encoded protein in rodents has been shown to bind PDGFA with a low affinity. [provided by RefSeq, Dec 2010]. * **UniProt Summary**: Enhances PDGFA-stimulated cell growth in fibroblasts, but inhibits the mitogenic effect of PDGFB. {ECO:0000250}. |PP28| |ficolin-1-rich granule lumen| |neutrophil degranulation| |neutrophil activation involved in immune response| |neutrophil mediated immunity| |neutrophil activation| |granulocyte activation| |leukocyte degranulation| |myeloid leukocyte mediated immunity| |myeloid cell activation involved in immune response| |myeloid leukocyte activation| |leukocyte activation involved in immune response| |cell activation involved in immune response| |regulated exocytosis| |leukocyte mediated immunity| |exocytosis| |leukocyte activation| |secretion by cell| |export from cell| |cell activation| |immune effector process| |secretion| |RNA binding| |immune response| |extracellular region| |vesicle-mediated transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp32|Rifampicin 10μM R00 exp32]]|-2.46| |[[:results:exp169|BH1 1μM R04 exp169]]|-2.45| |[[:results:exp412|THZ531 0.11 to 0.125 to 0.35μM on day4 then day6 R07 exp412]]|-2.42| |[[:results:exp247|UM0130462 0.025 to 0.035μM day4 R05 exp247]]|-2.34| |[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|-2.27| |[[:results:exp365|I-BRD9 4μM R07 exp365]]|-2.21| |[[:results:exp35|TRAIL 5ng/ml R00 exp35]]|-2.19| |[[:results:exp122|Golgicide-A 4μM R03 exp122]]|-2.17| |[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|-2.14| |[[:results:exp187|proTAME 5μM R04 exp187]]|-2.12| |[[:results:exp470|Chloroquine 32μM R08 exp470]]|-2.06| |[[:results:exp162|BI-D1870 2μM R04 exp162]]|-2.03| |[[:results:exp406|Thalidomide 20μM R07 exp406]]|-1.98| |[[:results:exp180|Dynasore 10μM R04 exp180]]|-1.93| |[[:results:exp37|Wortmannin 0.5μM R00 exp37]]|-1.86| |[[:results:exp38|Wortmannin 5μM R00 exp38]]|-1.83| |[[:results:exp273|Cisplatin 0.35μM R06 exp273]]|-1.79| |[[:results:exp415|Trichostatin-A 0.06μM R07 exp415]]|-1.79| |[[:results:exp151|SGC0946 7μM R03 exp151]]|-1.75| |[[:results:exp36|TRAIL 50ng/ml R00 exp36]]|-1.74| |[[:results:exp437|Ethanol 0.003 R08 exp437]]|-1.73| |[[:results:exp282|Fluvastatin 2.2μM R06 exp282]]|-1.73| |[[:results:exp175|3-Bromopyruvate 7μM R04 exp175]]|-1.71| |[[:results:exp352|Dexamethasone 0.006 to 0.015μM on day4 R07 exp352]]|-1.71| |[[:results:exp231|Epothilone-B 0.0015μM R05 exp231]]|-1.71| |[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|-1.71| |[[:results:exp217|Mdivi-1 15μM R05 exp217]]|1.94| |[[:results:exp209|Deguelin 0.15μM R05 exp209]]|2.05| |[[:results:exp64|Nocodazole 0.2μM R02 exp64]]|2.11| ^Gene^Correlation^ |[[:human genes:t:thg1l|THG1L]]|0.563| |[[:human genes:u:uap1|UAP1]]|0.515| |[[:human genes:m:mbtps2|MBTPS2]]|0.507| |[[:human genes:r:rptor|RPTOR]]|0.502| |[[:human genes:t:ttc4|TTC4]]|0.497| |[[:human genes:d:dpagt1|DPAGT1]]|0.493| |[[:human genes:u:urm1|URM1]]|0.491| |[[:human genes:p:ppp6c|PPP6C]]|0.487| |[[:human genes:d:dohh|DOHH]]|0.486| |[[:human genes:e:eef1e1|EEF1E1]]|0.483| |[[:human genes:a:alg1|ALG1]]|0.482| |[[:human genes:t:trmt10a|TRMT10A]]|0.478| |[[:human genes:d:dhrsx|DHRSX]]|0.477| |[[:human genes:e:elp3|ELP3]]|0.464| |[[:human genes:p:pmm2|PMM2]]|0.464| |[[:human genes:e:eif1|EIF1]]|0.462| |[[:human genes:g:gtf3c6|GTF3C6]]|0.46| |[[:human genes:s:srp14|SRP14]]|0.459| |[[:human genes:s:sec63|SEC63]]|0.458| |[[:human genes:g:gmppb|GMPPB]]|0.457| |[[:human genes:t:trmt61a|TRMT61A]]|0.454| |[[:human genes:p:pelo|PELO]]|0.45| |[[:human genes:n:nsd1|NSD1]]|0.45| |[[:human genes:r:rpp21|RPP21]]|0.45| |[[:human genes:r:rnmt|RNMT]]|0.449| |[[:human genes:g:gtf3c4|GTF3C4]]|0.445| |[[:human genes:m:med16|MED16]]|0.445| |[[:human genes:i:irf2bp2|IRF2BP2]]|0.444| |[[:human genes:s:sec62|SEC62]]|0.443| |[[:human genes:e:exoc4|EXOC4]]|0.443| |[[:human genes:x:xpot|XPOT]]|0.443| |[[:human genes:k:kdsr|KDSR]]|0.434| |[[:human genes:o:oraov1|ORAOV1]]|0.434| |[[:human genes:e:elp2|ELP2]]|0.432| |[[:human genes:m:mtor|MTOR]]|0.43| |[[:human genes:a:alg6|ALG6]]|0.429| |[[:human genes:b:bap1|BAP1]]|0.429| |[[:human genes:t:tsen54|TSEN54]]|0.428| |[[:human genes:r:rtcb|RTCB]]|0.425| |[[:human genes:f:fh|FH]]|0.424| |[[:human genes:t:ten1|TEN1]]|0.424| |[[:human genes:t:trim28|TRIM28]]|0.424| |[[:human genes:c:cmtr1|CMTR1]]|0.424| |[[:human genes:z:znf608|ZNF608]]|0.422| |[[:human genes:e:elp6|ELP6]]|0.422| |[[:human genes:r:romo1|ROMO1]]|0.421| |[[:human genes:g:gfpt1|GFPT1]]|0.419| |[[:human genes:t:tmem41b|TMEM41B]]|0.418| |[[:human genes:d:dnajc3|DNAJC3]]|0.418| |[[:human genes:s:ssb|SSB]]|0.416| |[[:human genes:a:atxn10|ATXN10]]|0.413| |[[:human genes:v:vezt|VEZT]]|0.413| |[[:human genes:a:alg2|ALG2]]|0.408| |[[:human genes:t:trmt5|TRMT5]]|0.406| |[[:human genes:t:triap1|TRIAP1]]|0.406| |[[:human genes:c:ctu1|CTU1]]|0.406| |[[:human genes:s:slc25a19|SLC25A19]]|0.405| |[[:human genes:p:ppp2r3c|PPP2R3C]]|0.405| |[[:human genes:n:nrd1|NRD1]]|0.404| |[[:human genes:t:tti2|TTI2]]|0.404| |[[:human genes:d:dnlz|DNLZ]]|0.403| |[[:human genes:l:lsm11|LSM11]]|0.402| |[[:human genes:u:ube2g2|UBE2G2]]|0.402| |[[:human genes:x:xpo6|XPO6]]|0.4| Global Fraction of Cell Lines Where Essential: 462/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|1/1| |bile duct|17/28| |blood|20/28| |bone|15/26| |breast|17/33| |central nervous system|28/56| |cervix|1/4| |colorectal|15/17| |esophagus|4/13| |fibroblast|1/1| |gastric|9/16| |kidney|15/21| |liver|17/20| |lung|49/75| |lymphocyte|10/16| |ovary|10/26| |pancreas|18/24| |peripheral nervous system|11/16| |plasma cell|5/15| |prostate|1/1| |skin|18/24| |soft tissue|7/9| |thyroid|1/2| |upper aerodigestive|15/22| |urinary tract|20/29| |uterus|3/5| == Essentiality in NALM6 == * **Essentiality Rank**: 6028 * **Expression level (log2 read counts)**: 6.68 {{:chemogenomics:nalm6 dist.png?nolink |}}